Latest Breaking News On - Ibn sohm inc - Page 1 : comparemela.com

SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing

SOHM, Inc. Further Advances its Work in the Field of Genome Editing and ABBIE, a Retroviral Integrase with Linked Guided DNA Binding Domain.

SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

SOHM Files Provisional Patent on ABBIE's 'Smart Gene-Editing' That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations

SOHM Files Provisional Patent on ABBIE's 'Smart Gene-Editing' That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations -January 09, 2024 at 09:31 am EST

CHINO HILLS, Calif., Jan. 09, 2024 via IBN SOHM, Inc. , a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and markets generic drugs covering numerous.

SOHM Files Provisional Patent on ABBIE's 'Smart Gene-Editing' That Uses Latest Enzymes and ... | Region

CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) via IBN SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and markets